This study was to investigate the effects of high intensity focused ultrasound on vascular endothelial growth factor. A B16 melanoma model was adopted in our study. Melanoma bearing mice were randomly divided into two groups: HIFU group and surgery group. While the control group was only injected with isovolumetric normal saline solution and treated as the surgery group. We detected VEGF both in tissues and sera through immunohistochemical method and ELISA respectively. Tissues were sampled pre-and at the 3rd day postoperation in HIFU group and blood samples were taken pre-and at the 1st, 3rd, and 7th day post-operation in all the groups. As a result, in the tissues, VEGF was expressed in 80% melanomas, but none was detected in the targeted area after HIFU treatment. In the sera, there was a decreasing tendency of serum-VEGF concentrations in group HIFU and surgery after operation, while that in the control group increased after operation. The levels in the HIFU group on day 1, 3, and 7 postoperatively were all lower than that in the surgery group respectively (79.16 pg/ml vs 91.59 pg/ml; 33.64 pg/ml vs 49.39 pg/ml; 30.37 pg/ml vs 46.68 pg/ml), but there wasn't any significant difference (P > 0.05). So HIFU can destroy VEGF in the targeted area and maybe have less of an effect on serum-VEGF than surgery.
Introduction
Angiogenesis, in which many cytokines are involved, plays a very important role in the development and metastasis of cancers. Investigations reveal that a mass cannot grow beyond a volume of 3 mm 3 without a blood supply (1, 2). Furthermore, cancer therapies, which suppress tumors via inhibiting angiogenesis, are under development. Of those cytokines that participate in the control of angiogenesis, the role of vascular endothelial growth factor (VEGF) has been manifested (3, 4) . It was reported that the trauma and the stress attributable to an operation could lead to a higher level of VEGF in the local area and in the serum, thus increasing the risk of metastasis (5, 6) .
High intensity focused ultrasound (HIFU) ablates tissues via effects of heat, cavitation and mechanism (7, 8) . It has been used for clinical cancer treatment, and preliminary study has proved it efficient (9, 10) . A major worry about this modality is that it increases the risk of metastasis. Oosterhof et al reported that a high energy shock wave enhanced the metastasis in rat animal models bearing cancers with high metastatic potential, AT-6 Dunning R3327 prostate cancer (11). Some investigations believed that ultrasonic therapy didn't promote the development and spread of cancers (12).
Melanomas, which have a very highly metastatic potential, are an idea model to investigate angiogenesis. Considering the role of VEGF in angiogenesis, the effects of HIFU on VEGF was explored in a melanoma bearing mouse in the present study.
Materials and Methods

Animal Model
C57BL/6J mice, weighing 18-25g, (Laboratory Animal Center, Chongqing Medical University, Chongqing, China) were adopted in the present study. B16 melanoma cells were cultured in a RPMI 1640 medium enriched with 10% newborn calf serum. One hundred microlitter single-cell suspension (1.0 × 10 6 cells) was injected subcutaneously in dorsal region. After 7 days, the implanted tumor was formed. The length (L, mm) and width (W, mm) of the tumor were calibrated and the volume (V) was calculated using the following formula (13):
The experiment was scientifically and ethically approved by our university and complied with Practice for Laboratory Animals in China.
Therapy
Tumor bearing animals were randomly divided into 2 groups: HIFU and surgery (n=40 for each group). Another 40 normal mice were only injected 50 µl isovolumetric saline solution, which served as control and were treated after 7 days.
In the surgery group, both the tumor and its marginal skin tissue within 5 mm were removed. Animals in the control group also received an operation, in which 1.5 cm diameter skin tissue was resected.
HIFU Treatment: Mice in the HIFU group received focused ultrasonic therapy. This system was designed and manufactured by Chongqing Haifu Technology, Chongqing, China. The parameter of HIFU was 3 mm-5 mm in focal depth, 40 w/cm 2 in intensity and 10 MHz in frequency. A calibrated polyvinylidene difluoride membrane hydro-phone with spot diameter 0.5 mm (Shanghai Jiao Tong University, Shanghai, China) was used to map this acoustic pressure field. HIFU was performed as a manner of linear scan. The transducer was placed on the surface of the skin and swept across the focal region with a speed of 0.5-1 mms -1 ( Fig. 1 ). During the treatment, the skin was kept wet by using the degassed water. Thus, therapeutic ultrasound waves could efficiently reach the target volume. Cumulative ultrasonic duration was 250s~300s. The region of this operation also included the tumor and its marginal skin tissue within 5 mm.
Determination of HIFU Therapeutic Effects:
Animals were sacrificed after HIFU. The exposed tissues were removed. We performed continuous slice from the margin to the center. HE staining was adopted to confirm whether there were intact tissues within the exposed volume.
Determination of VEGF Protein in the Tissues
The targeted tissues were examed in HIFU group. Samples were taken pre-and at the 3rd day post-HIFU (n=10 for each day). All these samples were embedded in paraffin, Crystal sections 5 µm thick were then mounted on siliconecoated slides. The VEGF protein was immunohistochemically identified using an anti-mouse VEGF mAb (Santa Cruz Biotechnology) followed by an immunoperoxidase staining using ultrasensitive™ SP kit (mouse) (Maxim Pharmaceuticals).
Immunoreactivity was considered positive if there was a cytoplasmic staining of cells more than 1%.
ELISA for VEGF in the Sera
The levels of serum-VEGF (s-VEGF) were determined by enzyme linked immunosorbent assay (ELISA; Quantikine M; R&D Systems). The sera of the mice were collected pre-and 1st, 3rd, and 7th day post-operation (that was 0, 1, 3, 7 days and n=10 for each day) in all the groups. All blood samples were clotted for 2 hours at room temperature before centrifuging for 20 minutes at approximately 2000g. The sera and store samples were removed at -20 ºC for detecting.
All the procedures were carried out at the room temperature. The samples were added first and incubated for 2 hours. Then the peroxidase-conjugated anti-mouse VEGF was applied in each well and also incubated for 2 hours. At last, peroxidase substrate was added with a reactive time of 30 min. The optical density was measured at 450 nm/540 nm using a BIO-RAD550 microplate.
Statistics
All the data were processed by the statistics software SAS 8.0. The Q test was also adopted. The difference was significant if P value was < 0.05.
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Results
Therapeutic Effect
After HIFU treatment, HE staining of continuous slice showed that the tissues were completely coagulative necrosis within the exposed volume. The targeted area was eosinphage staining and non-tissue shapable. Karyopyknosis, karyorrhexis and karyolysis can be observed (Fig. 2, 3) .
The Expression of VEGF in the Tissues
Before HIFU treatment, Positive staining for VEGF was found in 8/10 melanomas, VEGF was mainly localized in the cytoplasm of tumor cells. After HIFU treatment, no VEGF protein was detected in the targeted area in any sample. There was significant difference between before and after HIFU treatment (P < 0.05) (Fig. 4, 5) .
The Expression of VEGF in the Sera
Before operation, the s-VEGF concentrations of all the mice were lower than 7.8 pg/ml in the control group. While in groups of melanoma bearing mice, it ranged from 90.78 pg/ml to 208.14 pg/ml (p < 0.01).
After operation, there was a decreasing tendency of s-VEGF concentrations in group HIFU and surgery. But until the 7th day, they didn't return to normal. While in the control group, the s-VEGF concentrations increase sharply at the first postoperative day and then decreased gradually on the following days. The concentration of the first postoperative day was the highest among all the postoperative days whether in HIFU, surgery, or control group. The levels in the HIFU group on day 1, 3, and 7 postoperatively were all lower than that in the surgery group, but no significant difference was found on any day (P > 0.05) (Table I, Fig. 6 ). 
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Figure 4:
The cytoplasm of tumor cells was strongly stained with mouse monoclonal antibodies for VEGF before HIFU treatment (400×).
Figure 5:
No VEGF positive tumor cells were detected in the targeted area after HIFU treatment (400×).
Discussion
VEGF is a vascular endothelial cell-specific growth factor. It can stimulate the proliferation and migration of endothelial cells (5). Many tumors, including melanomas, express this protein, which can be detected both in the local tissue and in the peripheral serum (14, 15) . In this study, VEGF in the local area was expressed in 80% melanomas and the level of s-VEGF was 90.78 pg/ml~208.14 pg/ml, which was significantly different from the normal tissues and was in agreement with other studies (14, 16) .
High intensity focused ultrasound (HIFU) is a non-invasive local therapy. The local temperature will increase sharply up to 65 ºC within 1~2 seconds, thus resulting in coagulative necrosis within the focused volume (9, 10). In this process, both tumor cells and blood vessels are destroyed (17, 18) . It have been demonstrated many factors were negatively expressed at the targeted area, including PCNA, CD44V6 and . In our study, VEGF was also negatively expressed. These results may be related to the heat and mechanism effect of HIFU, which would induce the protein coagulating or degenerating. So as far as this study was concerned, HIFU did not promote the metastasis of cancer.
Many studies reported that the level of s-VEGF increased transiently after surgery (6, (20) (21) (22) . And the more severe the trauma was, the more the angiogenic factors increased. The reason why angiogenic factors were influenced by the trauma was not clear. Some investigators believed that peripheral platelets of cancer contained much more VEGF mRNA and protein which were released during hemolysis and hemostasis (23, 24). However, the increasing of s-VEGF would promote the angiogenesis of micro-metastasis, Maniwa reported that the level of s-VEGF increased after operation in lung cancers and the metastasis was much more in surgery group than that in non-surgery group (21).
There was a decreasing tendency of s-VEGF concentration in the HIFU and surgery group after operation. However, VEGF did not return to normal even on the 7th day. The reason why HIFU induced higher level of s-VEGF remained unclear. It was reported that HIFU could destroy the platelet by the shearing of its cavitation effect (25), which maybe partly accounted for that.
The levels of s-VEGF in HIFU group were lower than that in surgery group on all the postoperative days though no significant difference was found between these two groups, suggesting HIFU maybe had less effect than surgery on VEGF. Further investigations should concentrate on the comparison of VEGF between HIFU and surgery. 
